SUBSEQUENT EVENTS (Details Narrative) - USD ($)			6 Months Ended
SUBSEQUENT EVENTS (Details Narrative) - USD ($)	Aug. 13, 2025	May 08, 2025	Jun. 30, 2025	Aug. 14, 2025	Aug. 04, 2025	Jul. 08, 2025
Defined Benefit Plan Disclosure [Line Items]
Working Capital Loan				$ 150,000	$ 1,000,000
Extension Meeting		In connection with the August 2025 Special Meeting, the Company’s shareholders approved a special resolution to amend the Charter to extend the date by which the Company must either consummate an initial Business Combination or (i) cease its operations, except for the purpose of winding up if it fails to complete an initial Business Combination and (ii) redeem all of the Public Shares included as part of the units sold in the Company’s initial public offering, from August 9, 2025 to November 9, 2025. In connection with the August 2025 Extension Amendment, the holders of 1,114,441 Class A Ordinary Shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $12.07 per share, for an aggregate redemption amount of $13,449,620.23, leaving approximately $18,415,659 in the Company’s trust account.
Fourth Extension Loan [Member]
Defined Benefit Plan Disclosure [Line Items]
Contribution sponsor						$ 60,000
Convertible promissory note description			(x) $60,000 and (y) $0.03 for each Public Share that was not redeemed in connection with the 2025 Special Meeting for each month (or a pro rata portion thereof if less than a month) until August 9, 2025. The Fourth Extension Loan Contributions will be deposited into the Company’s trust account. The Fourth Extension Loan will not bear any interest and will be repayable by the Company upon the earlier of the date by which the Company must complete an initial Business Combination and the consummation of the Company’s initial Business Combination. The maturity date of the Fourth Extension Loan may be accelerated upon the occurrence of an Event of Default (as defined therein). Any outstanding principal under the Fourth Extension Loan may be prepaid at any time by the Company, at its election and without penalty. On May 14, 2025 and June 10, 2025, the Sponsor and Orion GP made aggregate contributions of approximately $60,000 and $60,000, respectively, to the trust account under the Fourth Extension Loan.
Fifth Extension Loan [Member]
Defined Benefit Plan Disclosure [Line Items]
Contribution sponsor				$ 30,518
Extension Loan [Member]
Defined Benefit Plan Disclosure [Line Items]
Convertible promissory note description	(x) $55,000 and (y) $0.02 for each Public Share (as defined below) that was not redeemed in connection with the August 2025 Special Meeting, for each month (or a pro rata portion thereof if less than a month) until the earlier of (i) the date of the closing of the Business Combination and (ii) November 9, 2025. The Contributions will be deposited into the Company’s Trust Account. The Fifth Extension Loan will not bear any interest and will be repayable by the Company upon the earlier of the date by which the Company must complete an initial Business Combination and the consummation of the Company’s initial Business Combination. The maturity date of the Extension Loan may be accelerated upon the occurrence of an Event of Default (as defined therein).		(x) $55,000 and (y) $0.02 for each Public Share (as defined below) that was not redeemed in connection with the August 2025 Special Meeting, for each month (or a pro rata portion thereof if less than a month) until the earlier of (i) the date of the closing of the Business Combination and (ii) November 9, 2025. The Contributions will be deposited into the Company’s Trust Account. The Fifth Extension Loan will not bear any interest and will be repayable by the Company upon the earlier of the date by which the Company must complete an initial Business Combination and the consummation of the Company’s initial Business Combination. The maturity date of the Fifth Extension Loan may be accelerated upon the occurrence of an Event of Default (as defined therein).

Rigel Resource Acquisition Corp. 10-Q